{"format":1,"id":"117-hr-941","congress":117,"number":"H.R. 941","kind":"bill","group":"bills","title":"TRANSPLANT Act of 2021","title_source":"Short Titles as Enacted","official_title":"To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.","titles":[{"type":"Official Title as Introduced","title":"To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes."},{"type":"Short Titles from ENR (Enrolled) bill text","title":"TRANSPLANT Act of 2021"},{"type":"Short Titles from ENR (Enrolled) bill text","title":"Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021"},{"type":"Short Titles from RFS (Referred to Senate) bill text","title":"Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021"},{"type":"Short Titles from RFS (Referred to Senate) bill text","title":"TRANSPLANT Act of 2021"},{"type":"Display Title","title":"TRANSPLANT Act of 2021"},{"type":"Short Title(s) as Passed House","title":"TRANSPLANT Act of 2021"},{"type":"Short Title(s) as Passed House","title":"Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021"},{"type":"Short Title(s) as Introduced","title":"Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021"},{"type":"Short Title(s) as Introduced","title":"TRANSPLANT Act of 2021"},{"type":"Short Titles as Enacted","title":"TRANSPLANT Act of 2021"},{"type":"Short Titles as Enacted","title":"Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021"},{"type":"Short Titles as Passed Senate","title":"TRANSPLANT Act of 2021"},{"type":"Short Titles as Passed Senate","title":"Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021"}],"outcome":"became_law","law_number":"Public Law 117-15","introduced":"2021-02-08","chambers":{"house":{"status":"roll_call","date":"2021-04-15","vote":{"id":"117-2021-h109","question":"On Motion to Suspend the Rules and Pass","title":"TRANSPLANT Act","result":"Passed","yea":415,"nay":2,"present":0,"not_voting":12,"source":"https://clerk.house.gov/evs/2021/roll109.xml"}},"senate":{"status":"voice","date":"2021-05-17","vote":null,"how":"voice_vote","words":"Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote."}},"president":{"status":"signed","date":"2021-05-26"},"vice_president_tie_breaker":null,"latest_action":{"text":"Became Public Law No: 117-15.","date":"2021-05-26"},"nominees":null,"amendments":[],"other_votes":[],"crs_summary":{"date":"2021-05-26","stage":"Public Law","blocks":[{"k":"h","t":"Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021"},{"k":"p","t":"This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant."},{"k":"p","t":"The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments."},{"k":"p","t":"In addition, the Government Accountability Office must report on the regenerative medicine workforce."}],"words":95},"summary":{"main_subject":{"text":"Reauthorizes the C.W. Bill Young Cell Transplantation Program and the cord blood inventory program through fiscal year 2026, adds a periodic review of adult stem cell science, and requires a GAO report on the regenerative medicine workforce.","cites":[{"label":"Sec. 2","href":"https://www.congress.gov/bill/117th-congress/house-bill/941/text/enr#H2571CAF11CC54936BB4E3E2C53210754:~:text=2.%20Reauthorization%20of%20the%20C"},{"label":"Sec. 3","href":"https://www.congress.gov/bill/117th-congress/house-bill/941/text/enr#H9585DC1BC9C34DB5A924B99E71875C9E:~:text=3.%20Cord%20blood%20inventory"},{"label":"Sec. 5","href":"https://www.congress.gov/bill/117th-congress/house-bill/941/text/enr#HF355B0D617A64B5A927C1098C73518CF:~:text=5.%20GAO%20report%20on%20regenerative%20medicine%20workforce"}]},"core_areas":["C.W. Bill Young Cell Transplantation Program","Cord blood inventory","Regenerative medicine using adult stem cells","Regenerative medicine workforce report"],"what_it_does":[{"text":"Requires the Secretary to convene the Advisory Council of the Cell Transplantation Program at least two times each calendar year.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/117th-congress/house-bill/941/text/enr#H2571CAF11CC54936BB4E3E2C53210754:~:text=2.%20Reauthorization%20of%20the%20C"}},{"text":"Requires the Secretary, at least every 2 years, to review the state of the science of using adult stem cells and birthing tissues to develop new types of therapies, for the purpose of considering their inclusion in the Program.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/117th-congress/house-bill/941/text/enr#H2571CAF11CC54936BB4E3E2C53210754:~:text=2.%20Reauthorization%20of%20the%20C"}},{"text":"Requires the Secretary, not later than June 30, 2025, to complete the second review and submit recommendations to the Senate and House committees named in the text.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/117th-congress/house-bill/941/text/enr#H2571CAF11CC54936BB4E3E2C53210754:~:text=2.%20Reauthorization%20of%20the%20C"}},{"text":"Replaces the Program's earlier authorization of appropriations with $31,009,000 for each of fiscal years 2022 through 2026.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/117th-congress/house-bill/941/text/enr#H2571CAF11CC54936BB4E3E2C53210754:~:text=2.%20Reauthorization%20of%20the%20C"}},{"text":"Authorizes $23,000,000 for each of fiscal years 2022 through 2026 to carry out the cord blood inventory section of the Stem Cell Therapeutic and Research Act of 2005.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/117th-congress/house-bill/941/text/enr#H9585DC1BC9C34DB5A924B99E71875C9E:~:text=3.%20Cord%20blood%20inventory"}},{"text":"Requires the Comptroller General to report within 2 years of enactment on the specialized health care workforce in regenerative medicine, including employment levels, projected gaps, training programs and recommendations.","cite":{"label":"Sec. 5","href":"https://www.congress.gov/bill/117th-congress/house-bill/941/text/enr#HF355B0D617A64B5A927C1098C73518CF:~:text=5.%20GAO%20report%20on%20regenerative%20medicine%20workforce"}}],"unexpected":[],"version":{"type":"Enrolled Bill","date":null,"rule":"enrolled","href":"https://www.congress.gov/bill/117th-congress/house-bill/941/text/enr"},"current":true,"model":"claude-sonnet-5-5","approved":"2026-10-15","approved_by":"checks"},"sources":{"congress_gov":"https://www.congress.gov/bill/117th-congress/house-bill/941","text":"https://www.congress.gov/bill/117th-congress/house-bill/941/text"},"card":{"image":"card/item/117-hr-941.png","v":"01a8a3195cd5","alt":"Votes on Record. H.R. 941, 117th Congress: TRANSPLANT Act of 2021. House: 415 Yea, 2 Nay. Senate: voice vote. Outcome: Became law, 26 May 2021."}}